<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001663'>Ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) and electrical storm remain challenging conditions to manage despite the availability of various treatment modalities </plain></SENT>
<SENT sid="1" pm="."><plain>Insertion of an implantable cardioverter defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) remains the gold standard method for lowering the risk of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> in patients deemed to be at greatest risk of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>However, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> do not alter the underlying substrate responsible for the arrhythmic events and a significant proportion of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> may experience <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> storm which may be life threatening and difficult to control with medication </plain></SENT>
<SENT sid="3" pm="."><plain>Catheter ablation (CA) of the triggers or abnormal electrical substrate responsible for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> storm is an important treatment option in rare cases </plain></SENT>
<SENT sid="4" pm="."><plain>In this article, we present an overview of the current theories underlying the mechanisms of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> and discuss how the technique of CA may be used to treat the triggers of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> and electrical storm </plain></SENT>
<SENT sid="5" pm="."><plain>We review the literature on outcomes in patients who have undergone CA for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> in a variety of different settings, including those with structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> and structurally <z:mpath ids='MPATH_458'>normal</z:mpath> hearts (e.g. patients with inherited arrhythmogenic diseases and idiopathic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) and discuss the future directions in this field </plain></SENT>
</text></document>